NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.
Learn more about NIDA Notes
Describes a voucher-based reinforcement therapy trial with pregnant smokers to determine its effectiveness in enhancing abstinence rates.
Highlights NIDA’s research portfolio to identify the genes and genetic processes responsible for a person’s vulnerability to drug abuse.
Reports on a study of cocaine abusers revealing that the Stroop test may predict which cocaine abusers are likely to drop out of therapy.
Remembers Dr. James A. Inciardi, founder and co-director of the Center for Drug and Alcohol Studies and professor at the University of Delaware, who died on November 23, 2009.
Reports on a study investigating the benefits of extended opioid maintenance therapy that included drug counseling and 12 weeks of therapy with buprenorphine and naloxone.
Reports trends in onset of injection drug use to infection with hepatitis C virus in developed countries and notes the influence of prevention efforts.
Describes a study of participants who had both substance abuse and bipolar disorder to investigate the potential benefits of integrated group therapy for this population.
Reports findings that a rare neuroreceptor may be linked to the intensive cravings cocaine abusers experience during their first weeks of abstinence.
Reports on several drugs that may ward off depression and anxiety, common withdrawal symptoms from cocaine, based on an animal study.
Announces NIDA Notes’ first place 2009 award that salutes superior communications efforts of government agencies.
Testing a Prospective Medication To Help People Avoid Relapse
The Rise and Fall of the Cocaine High
Electronic Tools for Use in the Continuum of Care for Patients With Addiction
Researchers Speak: Dr. Thomas Kosten